News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
328,950 Results
Type
Article (19683)
Company Profile (139)
Press Release (309128)
Section
Business (105281)
Career Advice (872)
Deals (18520)
Drug Delivery (93)
Drug Development (50690)
Employer Resources (79)
FDA (7645)
Job Trends (7720)
News (185676)
Policy (17305)
Tag
Academia (726)
Alliances (27757)
Alzheimer's disease (577)
Approvals (7627)
Artificial intelligence (87)
Bankruptcy (170)
Best Places to Work (5529)
Biosimilars (71)
Breast cancer (80)
Cancer (690)
Cardiovascular disease (68)
Career advice (707)
Cell therapy (105)
Clinical research (42017)
Collaboration (268)
Compensation (88)
COVID-19 (1075)
C-suite (67)
Data (762)
Diabetes (105)
Diagnostics (1728)
Drug pricing (97)
Earnings (38339)
Employer resources (73)
Events (47864)
Executive appointments (252)
FDA (7972)
Funding (189)
Gene therapy (93)
GLP-1 (506)
Government (1802)
Healthcare (5874)
Infectious disease (1129)
Inflammatory bowel disease (72)
Interviews (115)
IPO (7326)
Job creations (2431)
Job search strategy (646)
Layoffs (255)
Legal (4081)
Lung cancer (107)
Lymphoma (65)
Manufacturing (147)
Medical device (1957)
Medtech (1960)
Mergers & acquisitions (11276)
Metabolic disorders (363)
Neuroscience (769)
NextGen Class of 2024 (2351)
Non-profit (904)
Northern California (754)
Obesity (232)
Opinion (177)
Patents (83)
People (33018)
Pharmaceutical (78)
Phase I (13109)
Phase II (17785)
Phase III (14310)
Pipeline (319)
Policy (73)
Postmarket research (1616)
Preclinical (4594)
Radiopharmaceuticals (156)
Rare diseases (163)
Real estate (3164)
Regulatory (12209)
Research institute (816)
Resumes & cover letters (138)
Southern California (695)
Startups (2006)
United States (6893)
Vaccines (216)
Weight loss (198)
Date
Last 7 days (324)
Last 30 days (1138)
Last 365 days (17639)
2024 (17572)
2023 (19643)
2022 (25880)
2021 (26666)
2020 (24919)
2019 (20089)
2018 (15621)
2017 (17258)
2016 (16213)
2015 (18840)
2014 (14817)
2013 (12562)
2012 (13489)
2011 (13820)
2010 (12744)
Location
Africa (406)
Asia (24556)
Australia (3164)
California (1711)
Canada (833)
China (183)
Colorado (72)
Connecticut (68)
Europe (50663)
Florida (252)
Illinois (174)
Indiana (127)
Japan (66)
Maryland (251)
Massachusetts (1429)
Minnesota (99)
New Jersey (673)
New York (493)
North Carolina (377)
Northern California (754)
Ohio (64)
Pennsylvania (406)
South America (603)
Southern California (695)
Texas (232)
Washington State (157)
328,950 Results for "urogen pharma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
UroGen Pharma Appoints David Lin as New Chief Commercial Officer
UroGen Pharma Ltd. today announced that David Lin will join UroGen as its Chief Commercial Officer and member of the Executive Leadership Team.
June 3, 2024
·
11 min read
Press Releases
UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 6, 2024
·
2 min read
Press Releases
UroGen Pharma to Present at the Guggenheim Securities Healthcare Innovation Conference
November 5, 2024
·
1 min read
Pharm Country
UroGen Pharma Announces Commencement of Public Offering of Ordinary Shares and Pre-Funded Warrants
UroGen Pharma Ltd. announced that it has commenced an underwritten public offering, subject to market and other conditions, to issue and sell its ordinary shares and pre-funded warrants.
June 17, 2024
·
4 min read
Deals
UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 7, 2024
UroGen Pharma Ltd. today announced the grants of inducement restricted stock units (“RSUs”) and an option (“Option”) to 15 new employees in connection with their employment with UroGen.
June 7, 2024
·
2 min read
Pharm Country
UroGen Pharma to Host UGN-102 Virtual Data Event on June 13, 2024
UroGen Pharma Ltd. today shared additional details about the upcoming ENVISION virtual data event on Thursday, June 13, 2024, at 11:00 a.m. Eastern Time.
June 6, 2024
·
4 min read
Pharm Country
UroGen Pharma to Participate at Upcoming May 2024 Investor Conferences
UroGen Pharma Ltd., a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, announced that it will present at the following investor conferences in May.
May 7, 2024
·
1 min read
Pharm Country
UroGen Pharma to Present at the 45th Annual Goldman Sachs Global Healthcare Conference
UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that management will participate in a fireside chat at the 45th Annual Goldman Sachs Global Healthcare Conference to take place June 10-13, 2024.
June 5, 2024
·
1 min read
Press Releases
UroGen Pharma to Report Third Quarter Financial Results on Wednesday, November 6, 2024
October 30, 2024
·
1 min read
Business
UroGen Pharma to Report 2024 First Quarter Financial Results on Monday, May 13, 2024
UroGen Pharma Ltd. today announced that it will report 2024 first quarter financial results on Monday, May 13, 2024, prior to the open of the stock market.
May 3, 2024
·
1 min read
1 of 32,895
Next
